Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > BIOL Biolase > Key Indicators
BIOL Biolase
0.563
-0.019-3.26%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-18.17% 168.2121 -3.69% 194.4868 -15.49% 188.1668 -28.12% 179.9727
Receivable Turnover(T)
9.91% 11.0383 10.04% 8.9574 49.86% 9.7651 178.64% 10.7409
Inventory Turnover(T)
17.23% 1.9416 -3.90% 1.6881 11.29% 1.7156 25.49% 1.8815
Fixed Assets Turnover(T)
-14.31% 10.9698 -6.97% 14.3538 0.23% 14.0146 31.21% 14.1422
Total Asset Rate(T)
31.49% 0.9236 8.96% 0.791 22.22% 0.7252 30.16% 0.8138
ROIC
-52.27% -62.314% 52.83% -42.306% 65.82% -29.492% 59.32% -43.835%
ROE
-37.69% -109.949% 61.86% -69.903% 78.81% -52.751% 85.68% -95.223%
ROA
-36.97% -47.878% 51.91% -34.194% 69.02% -25.085% 63.05% -34.688%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -- -- -1.65% -251.907%
ROA 5 Year Average
-- -- -- -- -- -- 2.43% -56.235%
Average 5 Years ROIC
-- -- -- -- -- -- 7.13% -78.509%
Profitability Ratios TTM
Gross Margin
-1.84% 36.782% 34.10% 44.246% 55.08% 44.903% 55.65% 42.179%
Operating Margin
7.80% -45.315% 35.83% -36.521% 52.79% -34.796% 49.46% -41.125%
Net Margin
-4.16% -51.836% 55.87% -43.226% 74.65% -34.589% 71.61% -42.625%
EBITDA Margin
-13.60% -0.4632% -7.13% -0.3702% 50.69% -0.2788% 43.44% -0.3437%
R & D Expense Ratio
-8.83% 14.350% -8.17% 14.160% -18.66% 14.040% -4.87% 15.430%
Sales Expense Ratio
8.42% 43.250% 2.33% 42.150% -13.07% 40.250% -20.69% 39.140%
Administration Expense Rate
-20.94% 24.500% -26.58% 24.450% -35.01% 25.410% -33.03% 28.730%
Financial Health Ratios
Long-Term Debt to Equity Ratio
127.35% 102.619% 53.88% 66.260% 38.54% 74.408% -67.01% 59.792%
Total Assets to Common Equity
60.11% 309.316% 27.61% 235.272% 28.62% 243.893% -46.95% 219.608%
Debt to Asset Ratio
109.54% 107.057% 49.00% 68.994% 40.69% 76.990% -66.69% 61.401%
Current Ratio
-37.08% 2.4617 -27.07% 3.173 -34.83% 3.3392 13.96% 3.565
Quick Ratio
-60.90% 1.0758 -42.87% 1.8371 -47.80% 2.0429 25.37% 2.4711
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -- -- 75.20% -5.308%
Revenue CAGR(5Y)
-- -- -- -- -- -- 61.26% -5.431%
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
CEO: Mr. John R. Beaver
Market: NASDAQ
Listing Date: 11/12/1992
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist